Page 12 - Jay Olson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FTC, Amgen reach deal to allow $28b pharmaceutical merger

The Federal Trade Commission dropped its lawsuit to block drugmaker Amgen’s $28 billion deal to acquire Horizon Therapeutics, reaching a settlement that the agency said would prevent ‘’potential competitive harm.’’

United statesLina khanMatt phippsWilliam blairJay olsonDoug farrarWall street

FTC reaches deal, drops lawsuit to block Amgen-Horizon pharma merger

FTC reaches deal, drops lawsuit to block Amgen-Horizon pharma merger
washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.

United statesLina khanJay olsonMatt phippsWilliam blairFederal trade commissionHorizon therapeuticsWall street

Analysts raise Neurocrine Biosciences (NBIX) price target following Ingrezza approval

Analysts raise Neurocrine Biosciences (NBIX) price target following Ingrezza approval
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Akash tewariSam bougheddaOppenheimer jay olsonDrug administrationHuntington study groupNeurocrine biosciencesJay olson

Cognition Therapeutics, Inc (NASDAQ:CGTX) Q2 2023 Earnings Call Transcript

Operator: Good morning, ladies and gentlemen and welcome to Cognition Therapeutics Second Quarter 2023 Earnings Conference Call. My name is Jenny and I will be your conference operator today.

Noord hollandUnited statesJohn doyleDaniel kontoh boatengJay olsonTony caggianoLisa ricciardiAydin huseynovCharles duncanCognition therapeutics incAlzheimer clinical trial consortiumMichaelj fox foundationInternational journal of molecular scienceCognition therapeuticsCall transcript augustCognition therapeutics second quarter

Marinus Pharmaceuticals, Inc (NASDAQ:MRNS) Q2 2023 Earnings Call Transcript

Operator: Greetings and welcome to the Marinus Pharmaceuticals’ Second Quarter 2023 Financial Results and Business Update Call. At this time, all participants are in a listen-only mode.

United kingdomNew yorkUnited statesKristin rudisillAndrew tsaiSonia weigleCharles duncanChristy shaferStevene pfanstielJoon leeDouglas tsaoScott braunsteinMarc goodmanJoseph hulihanJoe hulihanSteve pfanstiel